2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy; Neil J. Stone; Alison L. Bailey; Craig Beam; Kim K. Birtcher; Roger S. Blumenthal; Lynne T. Braun; Sarah De Ferranti; Joseph Faiella-Tommasino; Daniel E. Forman; Ronald Goldberg; Paul A. Heidenreich; Mark A. Hlatky; Daniel W. Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E. Ndumele; Carl E. Orringer; Carmen A. Peralta; Joseph J. Saseen; Sidney C. Smith; Laurence Sperling; Salim S. Virani; Joseph Yeboah

doi:10.1161/CIR.0000000000000625

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy
, Neil J. Stone
, Alison L. Bailey
, Craig Beam
, Kim K. Birtcher
, Roger S. Blumenthal
, Lynne T. Braun
, Sarah De Ferranti
, Joseph Faiella-Tommasino
, Daniel E. Forman
, Ronald Goldberg
, Paul A. Heidenreich
, Mark A. Hlatky
, Daniel W. Jones
, Donald Lloyd-Jones
, Nuria Lopez-Pajares
, Chiadi E. Ndumele
, Carl E. Orringer
, Carmen A. Peralta
, Joseph J. Saseen

Sidney C. Smith, Laurence Sperling, Salim S. Virani, Joseph Yeboah

Research output: Contribution to journal › Review article › peer-review

3669 Citations (Scopus)

Original language	English (US)
Pages (from-to)	E1082-E1143
Journal	Circulation
Volume	139
Issue number	25
DOIs	https://doi.org/10.1161/CIR.0000000000000625
Publication status	Published - 18 Jun 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AHA Scientific Statements
Guidelines
biomarkers, coronary artery calcium score
cardiovascular disease
cholesterol, LDL-cholesterol
diabetes mellitus
drug therapy
ezetimibe
hydroxymethylglutaryl-CoA reductase inhibitors/statins
hypercholesterolemia
lipids
patient compliance
pharmacological
primary prevention
proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
risk assessment
risk reduction discussion
risk treatment discussion, secondary prevention

Access to Document

10.1161/CIR.0000000000000625

Cite this

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., De Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), E1082-E1143. https://doi.org/10.1161/CIR.0000000000000625

@article{af9ed9238f234038b4303059787ce502,

title = "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",

keywords = "AHA Scientific Statements, Guidelines, biomarkers, coronary artery calcium score, cardiovascular disease, cholesterol, LDL-cholesterol, diabetes mellitus, drug therapy, ezetimibe, hydroxymethylglutaryl-CoA reductase inhibitors/statins, hypercholesterolemia, lipids, patient compliance, pharmacological, primary prevention, proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors, risk assessment, risk reduction discussion, risk treatment discussion, secondary prevention",

author = "Grundy, \{Scott M.\} and Stone, \{Neil J.\} and Bailey, \{Alison L.\} and Craig Beam and Birtcher, \{Kim K.\} and Blumenthal, \{Roger S.\} and Braun, \{Lynne T.\} and \{De Ferranti\}, Sarah and Joseph Faiella-Tommasino and Forman, \{Daniel E.\} and Ronald Goldberg and Heidenreich, \{Paul A.\} and Hlatky, \{Mark A.\} and Jones, \{Daniel W.\} and Donald Lloyd-Jones and Nuria Lopez-Pajares and Ndumele, \{Chiadi E.\} and Orringer, \{Carl E.\} and Peralta, \{Carmen A.\} and Saseen, \{Joseph J.\} and Smith, \{Sidney C.\} and Laurence Sperling and Virani, \{Salim S.\} and Joseph Yeboah",

year = "2019",

month = jun,

day = "18",

doi = "10.1161/CIR.0000000000000625",

language = "English (US)",

volume = "139",

pages = "E1082--E1143",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "25",

}

Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, Braun, LT, De Ferranti, S, Faiella-Tommasino, J, Forman, DE, Goldberg, R, Heidenreich, PA, Hlatky, MA, Jones, DW, Lloyd-Jones, D, Lopez-Pajares, N, Ndumele, CE, Orringer, CE, Peralta, CA, Saseen, JJ, Smith, SC, Sperling, L, Virani, SS & Yeboah, J 2019, '2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines', Circulation, vol. 139, no. 25, pp. E1082-E1143. https://doi.org/10.1161/CIR.0000000000000625

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. / Grundy, Scott M.; Stone, Neil J.; Bailey, Alison L. et al.
In: Circulation, Vol. 139, No. 25, 18.06.2019, p. E1082-E1143.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

T2 - A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

AU - Grundy, Scott M.

AU - Stone, Neil J.

AU - Bailey, Alison L.

AU - Beam, Craig

AU - Birtcher, Kim K.

AU - Blumenthal, Roger S.

AU - Braun, Lynne T.

AU - De Ferranti, Sarah

AU - Faiella-Tommasino, Joseph

AU - Forman, Daniel E.

AU - Goldberg, Ronald

AU - Heidenreich, Paul A.

AU - Hlatky, Mark A.

AU - Jones, Daniel W.

AU - Lloyd-Jones, Donald

AU - Lopez-Pajares, Nuria

AU - Ndumele, Chiadi E.

AU - Orringer, Carl E.

AU - Peralta, Carmen A.

AU - Saseen, Joseph J.

AU - Smith, Sidney C.

AU - Sperling, Laurence

AU - Virani, Salim S.

AU - Yeboah, Joseph

PY - 2019/6/18

Y1 - 2019/6/18

KW - AHA Scientific Statements

KW - Guidelines

KW - biomarkers, coronary artery calcium score

KW - cardiovascular disease

KW - cholesterol, LDL-cholesterol

KW - diabetes mellitus

KW - drug therapy

KW - ezetimibe

KW - hydroxymethylglutaryl-CoA reductase inhibitors/statins

KW - hypercholesterolemia

KW - lipids

KW - patient compliance

KW - pharmacological

KW - primary prevention

KW - proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors

KW - risk assessment

KW - risk reduction discussion

KW - risk treatment discussion, secondary prevention

UR - https://www.scopus.com/pages/publications/85068374636

U2 - 10.1161/CIR.0000000000000625

DO - 10.1161/CIR.0000000000000625

M3 - Review article

C2 - 30586774

AN - SCOPUS:85068374636

SN - 0009-7322

VL - 139

SP - E1082-E1143

JO - Circulation

JF - Circulation

IS - 25

ER -

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):E1082-E1143. doi: 10.1161/CIR.0000000000000625

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

UN SDGs

Keywords

Access to Document

Other files and links

Cite this